| Literature DB >> 35600142 |
Hamid Hadi-Alijanvand1, Luisa Di Paola2, Guang Hu3, David M Leitner4, Gennady M Verkhivker5,6, Peixin Sun3, Humanath Poudel4, Alessandro Giuliani7.
Abstract
At the center of the SARS-CoV2 infection, the spike protein and its interaction with the human receptor ACE2 play a central role in the molecular machinery of SARS-CoV2 infection of human cells. Vaccine therapies are a valuable barrier to the worst effects of the virus and to its diffusion, but the need of purposed drugs is emerging as a core target of the fight against COVID19. In this respect, the repurposing of drugs has already led to discovery of drugs thought to reduce the effects of the cytokine storm, but still a drug targeting the spike protein, in the infection stage, is missing. In this work, we present a multifaceted computational approach strongly grounded on a biophysical modeling of biological systems, so to disclose the interaction of the SARS-CoV2 spike protein with ACE2 with a special focus to an allosteric regulation of the spike-ACE2 interaction. Our approach includes the following methodologies: Protein Contact Networks and Network Clustering, Targeted Molecular Dynamics, Elastic Network Modeling, Perturbation Response Scanning, and a computational analysis of energy flow and SEPAS as a protein-softness and monomer-based affinity predictor. We applied this approach to free (closed and open) states of spike protein and spike-ACE2 complexes. Eventually, we analyzed the interactions of free and bound forms of spike with hepcidin (HPC), the major hormone in iron regulation, recently addressed as a central player in the COVID19 pathogenesis, with a special emphasis to the most severe outcomes. Our results demonstrate that, compared with closed and open states, the spike protein in the ACE2-bound state shows higher allosteric potential. The correspondence between hinge sites and the Allosteric Modulation Region (AMR) in the S-ACE complex suggests a molecular basis for hepcidin involvement in COVID19 pathogenesis. We verify the importance of AMR in different states of spike and then study its interactions with HPC and the consequence of the HPC-AMR interaction on spike dynamics and its affinity for ACE2. We propose two complementary mechanisms for HPC effects on spike of SARS-CoV-2; (a) HPC acts as a competitive inhibitor when spike is in a preinfection state (open and with no ACE2), (b) the HPC-AMR interaction pushes the spike structure into the safer closed state. These findings need clear molecular in vivo verification beside clinical observations.Entities:
Year: 2022 PMID: 35600142 PMCID: PMC9113007 DOI: 10.1021/acsomega.2c00154
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Complex of the spike protein of SARS-CoV2 with the human receptor ACE2 (in yellow). (A) Complex spike–ACE2; (B) complex spike–ACE2 docked with the hepcidin (blue surface).
Figure 2Interface between two chains. In chain A, the length of the peptide segment participating in the interface accounts for seven residues (solid and empty blue bullets), and three of them are directly involved in four links (solid blue bullets). Analogously, chain B accounts for 12 residues in the interface, three of which are in direct contact with residues in chain A.
Figure 3General workflow of the multifaceted computational approach to the analysis of the allosteric behavior of the spike–ACE2 complex in the perspective of inhibition by hepcidin.
Figure 4Network clustering of closed conformation of the SARS-CoV2 spike protein: (A) the two clusters in the closed conformation are reported in green and red; (B) the active region (P > 0) in the two clusters partition.
Figure 5Network clustering of open (1-up) conformation of the SARS-CoV2 spike protein: (A) the two clusters in the closed conformation are reported in green and red; (B) the active region (P > 0) in the two clusters partition.
Figure 6Intrinsic dynamics of S proteins in closed, open, and bound states. (A) Overlap of 10 ANM modes between the closed and open states. (B) Overlap of 10 ANM modes between the open and bound states. (C) The square fluctuations of S proteins in three states based on the first ANM modes. The bounded RBD is most stable in the closed state (blue) but has the largest flexibility in the open state (green). The bounded RBD in the complex state has the lowest stability (red).
Hinge Sites in the SARS-CoV2 Spike–ACE2 Complex
| chain | A | B | C | D |
|---|---|---|---|---|
| hinge sites | 317N, 326I, 474Q, 475A, 477S, 479P, 485G, 487N, 488C, 533L, 543F, 545G, 578D, 582L, 595 V, 612Y, 620 V, 621P, 623A, 643F, 650L, 654Z, 664I, 673S, 693I, 730S, 735S, 742I, 743C, 746D, 761T, 780Z, 783A, 854 K, 856N, 858L, 860 V, 873Y, 949L, 986P, 991 V, 1005Q, 1058H | 14Q, 33T, 37Y, 55F, 56L, 59F, 221S, 272P, 295P, 309Z, 322P, 590C, 698S, 752L, 753L, 758S, 971G, 983R, 990Z, 1146D | 320 V, 369Y, 371S, 472I, 489Y, 591S, 658N, 662C, 667G, 671C, 695Y, 703N, 730S, 776 K, 826 V, 866T, 948L, 966L, 996L, 1013I, 1015A, 1146D | 19S, 31K |
Figure 7Allosteric properties of S proteins in closed, open, and bound states. (a–c) Distributions of the hinge sites (green beads) based on the first three GNM modes. (d) Comparison of effectiveness for three S proteins. (e) Effectiveness profiles for three S proteins, while their predicted AMR are labeled with black stars.
Figure 8Spike–ACE2 complex, with chain A, B, and C shown in green, cyan and magenta, respectively, and the ACE2 ectodomain in yellow. The five residues identified as having the largest influence on energy transport in the complex are indicated in red. They all lie in the AMR, previously identified as containing the residues with the largest participation number in the complex, labeled in dark blue.
Figure 9Network clustering of the equilibrated form of the spike–ACE2 complex. (a) Cluster partition; (b) participation coefficient P map; (c) complex chains.
Allosteric Modulation Region (AMR) in the Equilibrated Spike–ACE2 Complexa
| name | position | |
|---|---|---|
| VAL | 327 | 0.44 |
| 328 | 0.89 | |
| PHE | 329 | 0.19 |
| PRO | 330 | 0.17 |
| ASN | 331 | 0.56 |
| CYS | 525 | 0.13 |
| PRO | 527 | 0.51 |
| LYS | 528 | 0.31 |
| LYS | 529 | 0.36 |
| SER | 530 | 0.44 |
All residues are located in the C chain. In italic the most competent residue (Arg 328) in intermodule communication (P ≥ 0.75).
Allosteric Modulation Region in the Equilibrated Spike–ACE2 + Hepcidin Complexa
| name | position | |
|---|---|---|
| PHE | 342 | 0.61 |
| ASN | 343 | 0.36 |
| ALA | 344 | 0.36 |
| THR | 345 | 0.56 |
| ARG | 346 | 0.31 |
| TRP | 353 | 0.61 |
| 354 | 0.84 | |
| ARG | 355 | 0.31 |
| LYS | 356 | 0.27 |
| PHE | 374 | 0.40 |
| SER | 375 | 0.56 |
| THR | 376 | 0.56 |
| ASP | 398 | 0.51 |
| SER | 399 | 0.66 |
| PHE | 400 | 0.33 |
| VAL | 401 | 0.19 |
| VAL | 407 | 0.23 |
| PRO | 412 | 0.56 |
| LYS | 424 | 0.19 |
| LEU | 425 | 0.56 |
| PRO | 426 | 0.64 |
| 427 | 0.75 | |
| THR | 430 | 0.19 |
| VAL | 433 | 0.19 |
| ILE | 434 | 0.36 |
| ALA | 435 | 0.64 |
| 436 | 0.80 | |
| 437 | 0.75 | |
| TYR | 508 | 0.1736 |
| ARG | 509 | 0.5950 |
| 510 | 0.79 | |
| VAL | 511 | 0.3306 |
| VAL | 512 | 0.1900 |
All residues are located in the C chain. In italic font type the most competent residues in intermodule communication (P ≥ 0.75) are given.
Thermodynamic Parameters of Protein–Protein Interface (from PISA)[56]
| chains | Δ | pairs | Δ | Δ | Δ | ||
|---|---|---|---|---|---|---|---|
| S+A | A | –1080.1 | A-B | –43.3 | –130.7 | –9.7 | 16.0 |
| B | –1073.3 | B-C | –39.6 | ||||
| C | –1050.0 | A-C | –42.8 | ||||
| D | –453.3 | C-D | –5.0 | ||||
| S+A+H | A | –1014.7 | A-B | –46.8 | –183.4 | –5.6 | 15.9 |
| B | –1002.4 | B-C | –46.8 | ||||
| C | –1011.9 | A-C | –43.2 | ||||
| D | –524.7 | C-D | –7.4 | ||||
| S closed | A | –919.1 | A-B | –52.9 | 34.5 | 170.9 | 37.2 |
| B | –919.5 | B-C | –52.8 | ||||
| C | –919.5 | A-C | –52.8 | ||||
| S open | A | –888.3 | A-B | –49.6 | 28.5 | 163.8 | 37.2 |
| B | –864.2 | B-C | –45.9 | ||||
| C | –736.9 | A-C | –50.8 |
Interface Analysis through PCNs: The Complex Spike–ACE2 (without Hepcidin)
| ( | ⟨ | |||||||
|---|---|---|---|---|---|---|---|---|
| A-B | ||||||||
| 91 | 0.092 | 0.781 | 70.06 | 248 | 1.34 | 37.56 | 0.15 | |
| 94 | 0.115 | 0.643 | ||||||
| B-C | ||||||||
| 88 | 0.089 | 0.779 | 72.30 | 284 | 1.58 | 44.29 | 0.16 | |
| 92 | 0.112 | 0.643 | ||||||
| A-C | ||||||||
| 91 | 0.109 | 0.654 | 68.01 | 251 | 1.30 | 36.55 | 0.15 | |
| 95 | 0.096 | 0.781 | ||||||
| C-D | ||||||||
| 11 | 0.367 | 0.024 | 9.38 | 25 | 1.04 | 3.62 | 0.14 | |
| 13 | 0.039 | 0.563 | ||||||
Interface Analysis through PCNs: The Complex Spike–ACE2 (with Hepcidin)
| ( | ⟨ | |||||||
|---|---|---|---|---|---|---|---|---|
| A-B | ||||||||
| 109 | 0.101 | 0.852 | 90.80 | 294 | 1.27 | 44.69 | 0.15 | |
| 122 | 0.146 | 0.655 | ||||||
| B-C | ||||||||
| 86 | 0.080 | 0.846 | 64.20 | 211 | 1.25 | 31.45 | 0.15 | |
| 83 | 0.102 | 0.643 | ||||||
| A-C | ||||||||
| 146 | 0.134 | 0.853 | 107.01 | 338 | 1.23 | 50.55 | 0.15 | |
| 129 | 0.120 | 0.848 | ||||||
| C-D | ||||||||
| 12 | 0.245 | 0.039 | 10.50 | 34 | 1.26 | 5.34 | 0.16 | |
| 15 | 0.045 | 0.560 | ||||||
Figure 10Result of SWARM docking is presented. Trimeric spike protein acts as a receptor protein and hepcidin25 acts as a ligand molecule. Chain C of the spike trimer is presented as blue wire, and other chains of the spike are presented as gray dots.
Top 10 Solutions of SWARM Docking Are Presented for Trimeric and Monomeric Spike Protein as Receptor of Hepcidin25a
| # solution | energy, kcal/mol | position |
|---|---|---|
| trimeric spike (chain ABC) | ||
| 1 | –31.7 | |
| 2 | –29.44 | |
| 3 | –28.92 | RBM |
| 4 | –27.3 | |
| 5 | –24.13 | |
| 6 | –23.95 | near AMR[27.86] |
| 7 | –22.84 | |
| 8 | –21.94 | near AMR [24.70] |
| 9 | –21.89 | |
| 10 | –21.85 | |
| monomeric spike (chain C) | ||
| 1 | 15.63 | |
| 2 | –13.1 | |
| 3 | –26.14 | AMR [19.98] |
| 4 | –10.39 | |
| 5 | 21.68 | |
| 6 | 3.5 | |
| 7 | 4.78 | |
| 8 | –10.76 | |
| 9 | 0.59 | |
| 10 | –18.83 | RBM |
The stalk region is laid on the body of spike in this section. The distance between Hepcidin25 and AMR is presented in brackets.
Figure 11SEPAS-predicted affinity of trimeric spike protein for ACE2 in the presence of hepcidin25 in the AMR (ABCD-H) or its absence (ABCD).
Figure 12Effect of hepcidin25 on the dynamics of spike subunits. (A) Docked binding sites of hepcidin25 on chain C. (B) Measured angle is reported for Chain C, chain C with hepcidin25 in AMR (CH), chain C in association with ACE2 (CD), and hepcidin25 bonded to AMR of chain C in complex with ACE2 (CDH). (C) Results of hepcidin25 binding to chain C in association with other subunit chains and ACE2 (ABCD-HPC) or without hepcidin25 (ABCD).
Figure 13Results of hepcidin25 interaction with spike in different states. (A) Output of the TMD simulation for sampling the spike structure from closed to open states. The most important residues of the AMR, P > 0.5, are declared by sphere. (B) SWARM-predicted affinity of hepcidin25 for the RBM of spike chains along the transition from closed to open states. The horizontal axis represents the distance of the state to the open conformation of spike by computing the RMSD between the considered frame and the target structure in TMD. (C) Same story but for affinity between hepcidin25 and the AMR in monomeric spike. The size of the circle (B, C) correlates with the size of the SWARM suggesting the top cluster corresponds to the considered representative introduced receptor.
Figure 14Pair-interaction potential is computed for the AMR. The relative interaction potential is presented in the vertical axis. More negative potential means a higher amount of interactions. The horizontal axis represents the distance of the state to the open conformation of spike by computing the RMSD between the considered frame and the target structure in TMD.